Free Trial

EUDA Health (EUDA) Competitors

EUDA Health logo
$3.80 -0.08 (-2.06%)
Closing price 05/21/2025 03:54 PM Eastern
Extended Trading
$3.83 +0.03 (+0.89%)
As of 05/21/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

EUDA vs. EHAB, TALK, INNV, AUNA, CSTL, PSNL, FTRE, CELC, LFMD, and SBC

Should you be buying EUDA Health stock or one of its competitors? The main competitors of EUDA Health include Enhabit (EHAB), Talkspace (TALK), InnovAge (INNV), Auna (AUNA), Castle Biosciences (CSTL), Personalis (PSNL), Fortrea (FTRE), Celcuity (CELC), LifeMD (LFMD), and SBC Medical Group (SBC). These companies are all part of the "healthcare" industry.

EUDA Health vs.

EUDA Health (NASDAQ:EUDA) and Enhabit (NYSE:EHAB) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, profitability, media sentiment, community ranking and earnings.

EUDA Health has higher earnings, but lower revenue than Enhabit.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
EUDA Health$4.01M35.20-$10.04MN/AN/A
Enhabit$1.03B0.51-$80.50M-$2.77-3.77

Enhabit received 4 more outperform votes than EUDA Health when rated by MarketBeat users. However, 100.00% of users gave EUDA Health an outperform vote while only 17.24% of users gave Enhabit an outperform vote.

CompanyUnderperformOutperform
EUDA HealthOutperform Votes
1
100.00%
Underperform Votes
No Votes
EnhabitOutperform Votes
5
17.24%
Underperform Votes
24
82.76%

EUDA Health has a net margin of 0.00% compared to Enhabit's net margin of -11.24%. Enhabit's return on equity of 1.67% beat EUDA Health's return on equity.

Company Net Margins Return on Equity Return on Assets
EUDA HealthN/A N/A N/A
Enhabit -11.24%1.67%0.80%

Enhabit has a consensus price target of $8.50, suggesting a potential downside of 18.63%. Given Enhabit's higher possible upside, analysts plainly believe Enhabit is more favorable than EUDA Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
EUDA Health
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
4.00
Enhabit
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

EUDA Health has a beta of -0.05, meaning that its share price is 105% less volatile than the S&P 500. Comparatively, Enhabit has a beta of 1.61, meaning that its share price is 61% more volatile than the S&P 500.

In the previous week, Enhabit had 14 more articles in the media than EUDA Health. MarketBeat recorded 14 mentions for Enhabit and 0 mentions for EUDA Health. Enhabit's average media sentiment score of 1.38 beat EUDA Health's score of 0.00 indicating that Enhabit is being referred to more favorably in the news media.

Company Overall Sentiment
EUDA Health Neutral
Enhabit Positive

4.3% of EUDA Health shares are owned by institutional investors. 1.9% of Enhabit shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Enhabit beats EUDA Health on 10 of the 17 factors compared between the two stocks.

Get EUDA Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for EUDA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EUDA vs. The Competition

MetricEUDA HealthHealth services IndustryMedical SectorNASDAQ Exchange
Market Cap$141.18M$834.18M$5.37B$8.39B
Dividend YieldN/A2.30%5.22%4.10%
P/E RatioN/A52.7826.8419.71
Price / Sales35.2011.07392.34117.39
Price / CashN/A26.1438.2534.62
Price / Book-12.673.906.794.50
Net Income-$10.04M-$5.50M$3.23B$248.18M
7 Day Performance-3.80%4.52%1.53%0.20%
1 Month Performance-1.55%75.13%10.05%12.37%
1 Year Performance62.39%21.57%16.71%7.04%

EUDA Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EUDA
EUDA Health
N/A$3.80
-2.1%
N/A+63.1%$141.18M$4.01M0.002Positive News
Gap Down
EHAB
Enhabit
2.0795 of 5 stars
$10.38
-0.8%
$8.50
-18.1%
+12.7%$525.71M$1.03B-4.4710,900News Coverage
Positive News
TALK
Talkspace
3.7487 of 5 stars
$3.08
-0.2%
$4.50
+46.3%
+5.5%$516.26M$194.36M306.81500Positive News
INNV
InnovAge
1.0529 of 5 stars
$3.81
+0.3%
$5.00
+31.2%
-9.5%$515.28M$806.61M-20.052,000
AUNA
Auna
3.6715 of 5 stars
$6.87
-0.9%
$13.50
+96.6%
-22.3%$507.43M$4.39B18.0514,958News Coverage
Earnings Report
CSTL
Castle Biosciences
3.0353 of 5 stars
$16.63
-2.4%
$37.50
+125.5%
-35.7%$481.44M$347.08M83.38540News Coverage
Analyst Forecast
PSNL
Personalis
4.3518 of 5 stars
$5.09
-0.3%
$8.00
+57.3%
+225.5%$449.57M$85.69M-3.03400News Coverage
Gap Up
FTRE
Fortrea
3.3962 of 5 stars
$4.75
-8.5%
$15.82
+233.2%
-84.0%$433.96M$2.70B-1.4018,000Gap Down
CELC
Celcuity
2.1157 of 5 stars
$10.58
-1.0%
$30.17
+185.3%
-35.8%$402.61MN/A-4.0840News Coverage
Earnings Report
Analyst Forecast
Analyst Revision
LFMD
LifeMD
1.2631 of 5 stars
$8.52
-0.4%
$11.00
+29.1%
+39.7%$385.63M$234.01M-13.26230Gap Down
SBC
SBC Medical Group
N/A$3.65
+5.2%
N/AN/A$378.18M$205.42M0.00N/AEarnings Report
Analyst Revision

Related Companies and Tools


This page (NASDAQ:EUDA) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners